
Apply Now! 2 Day ESO Webinar To Equip Physicians with Guideline Development Skills
The European Stroke Organisation (ESO) shared an inviting post on X:
”You can still register for the webinar on developing ESO guidelines on 21 and 23 July 2025. Perfect for module working group members and physicians eager to learn about writing guidelines.”
To learn more, follow the link.
The European Stroke Organisation (ESO) is hosting a dedicated webinar designed for members of its module working groups and all physicians eager to enhance their expertise in clinical guideline development.
This educational session introduces participants to the GRADE methodology and the ESO Standard Operating Procedure (SOP) for developing evidence-based guidelines.
By providing structured training, the webinar aims to equip future module working group members with the tools necessary to streamline the process of drafting, evaluating, and publishing clinical guidelines.
Ultimately, this initiative fosters methodological rigor, accelerates the dissemination of best practices, and strengthens the quality of stroke care across Europe.
Do not miss your chance. Apply Now!
Stay informed on opportunities like this with Hemostasis Today .
-
Jul 20, 2025, 16:435 Reasons LD May Outperform EVD in aSAH: Is Lumbar Drainage the Superior Strategy?
-
Jul 18, 2025, 12:18NBCA Hosts PEP Talk with Dr. Parks on Aging and Blood Clots
-
Jul 18, 2025, 12:14WFH Shares Powerful Patient Story on Access to Bleeding Disorders Treatment
-
Jul 18, 2025, 11:53HTRS Shines Spotlight on Faculty Powering the Future of Hemostasis and Thrombosis
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 20, 2025, 17:12Thromboelastography: Coagulation Beyond INR and aPTT
-
Jul 20, 2025, 16:555 Crucial Insights into Low VWF QL: Uncovering a Distinct Cause of Bleeding
-
Jul 19, 2025, 17:16Promising 85% Response: Ru-D Regimen Shows Hope for Adults with HLH
-
Jul 19, 2025, 16:16A Potential Link to Recurrent Pregnancy Loss: Monoclonal Anti-PF4 Antibodies' Role
-
Jul 19, 2025, 15:2115% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 20, 2025, 17:17Michael Makris Shares 2 Fascinating Lessons from Hemophilia Care in Japan
-
Jul 16, 2025, 10:24Salma Ismail: Honored to Be Invited By the EHA2025 as Part of Their Lighting the Flame Program
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy